AlignMap In Cites
AlignMap In Cites offers annotated links to web sites, news, research, and other material relevant to treatment adherence & patient compliance. AlignMap In Cites, the AlignMap Web Site, the AlignMap Weblog, and the AlignMap Furl Archive are produced by Allan Showalter, MD
Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post-Myocardial Infarction Medicare Beneficiaries -- Choudhry et al. 117 (10): 1261 -- Circulation
Results (excerpt): In the model, post–myocardial infarction Medicare beneficiaries who received usual prescription drug coverage under the Part D program lived an average of 8.21 quality-adjusted life-years after their initial event, incurring coronary heart disease–related medical costs of $114 000. Those who received prescription drug coverage without deductibles or copayments lived an average of 8.56 quality-adjusted life-years and incurred $111 600 in coronary heart disease–related costs. Compared with current prescription drug coverage, full coverage for post–myocardial infarction secondary prevention therapies would result in greater functional life expectancy (0.35 quality-adjusted life-year) and less resource use ($2500). From the perspective of Medicare, full drug coverage was highly cost-effective ($7182/quality-adjusted life-year) but not cost saving.
Note that this estimate is based on an economic model rather than a study of actual patients.